FDA panel backs NPS Pharmaceuticals (NPSP) Gattex
Tweet
Share
E-mailGet Alerts NPSP Hot Sheet
Join SI Premium – FREE
FDA panel backs NPS Pharmaceuticals' (NASDAQ: NPSP) Gattex
(NOTE: shares have been halted all day in anticipation of the adcom)
(NOTE: shares have been halted all day in anticipation of the adcom)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Regeneron's Pasatru for rare bone disorder FOP
- Keenova doses first patient in Phase 3 hammer toe drug trial
- FDA clears Implantica's RefluxStop implant for U.S. market
Create E-mail Alert Related Categories
FDA, Hot FDA News, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
